Global Companion Animal Vaccines Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Companion Animal Vaccines Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies), Animal Type (Dogs, Cats, and Other Animal Types), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Companion Animal Vaccines Market was valued at USD 3,334.0 million in 2023 and is expected to reach USD 5,362.2 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global companion animal vaccines market growth. Companion animal vaccines are biologics crafted to elicit an immune response in pets like dogs and cats, crucial in preventing and controlling infectious diseases that impact their health. These vaccines, akin to human vaccines, are Animal Typeed to grant immunity against specific pathogens, including viruses and bacteria.
Increasing awareness of zoonotic diseases and advancements in vaccine technology are expected to drive significant growth in the Companion Animal Vaccines market. Despite this potential, market expansion may encounter challenges such as stringent regulatory requirements, approval processes, and a lack of awareness among pet owners and veterinarians.
Furthermore, the global companion animal vaccines industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Companion Animal Vaccines Market is segmented among Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies, based on Technology. In 2023, Live Attenuated Vaccines accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Animal Type Analysis
The Global Companion Animal Vaccines Market is segmented among Dogs, Cats, and Other Animal Types, based on Animal Type. In 2023, Dogs accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Companion Animal Vaccines Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Brilliant Bio Pharma, Merck & Co. Inc., Virbac, Zoetis Inc., Indian Immunologicals Ltd, Bioveta AS, Durvet Inc., and HIPRA.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Companion Animal Vaccines Market Dynamics
Drivers
Restraints
Opportunity
4. Global Companion Animal Vaccines Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Companion Animal Vaccines Market Segmentation, By Technology
Global Companion Animal Vaccines Market Share Analysis, By Technology
Global Companion Animal Vaccines Market Growth Analysis, By Technology
Global Companion Animal Vaccines Market Trends, By Technology
o Live Attenuated Vaccines
o Inactivated Vaccines
o Toxoid Vaccines
o Recombinant Vaccines
o Other Technologies
6. Global Companion Animal Vaccines Market Segmentation, By Animal Type
Global Companion Animal Vaccines Market Share Analysis, By Animal Type
Global Companion Animal Vaccines Market Growth Analysis, By Animal Type
Global Companion Animal Vaccines Market Trends, By Animal Type
o Dogs
o Cats
o Other Animal Types
7. Global Companion Animal Vaccines Market Segmentation, By Region
Global Companion Animal Vaccines Market Share Analysis, By Region
Global Companion Animal Vaccines Market Growth Analysis, By Region
Global Companion Animal Vaccines Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Elanco Animal Health Incorporated*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Boehringer Ingelheim GmbH
Brilliant Bio Pharma
Merck & Co. Inc.
Virbac
Zoetis Inc.
Bioveta AS
Durvet Inc.
HIPRA
*Similar analysis will be provided for each company listed above.